NCT02303977 2021-09-29
Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
Abramson Cancer Center at Penn Medicine
Royal Marsden NHS Foundation Trust